(Total Views: 363)
Posted On: 10/15/2020 12:55:59 PM
Post# of 88

$SAGE News Article - Sage Therapeutics Announces Positive Interim, Topline Zuranolone Safety and Tolerability Data from Open-Label SHORELINE Study in Patients with MDD https://marketwirenews.com/news-releases/sage...91001.html


My Twitter: WhyteStocks